The expanding Gram-negative antibiotic pipeline offers important new treatment options; however, FDA approval alone does not define a drug’s place in therapy. Clinicians must weigh the clinical ...
GSK presented positive phase 2 results for its investigational mRNA seasonal influenza vaccine candidate at the OPTIONS XIII ...
Vibrio species are bacteria that live in salt water environments. When ingested orally or though contact with open wounds, some species can cause severe life-threatening infections, particularly in ...
The agency also cleared multiple updated COVID-19 vaccines for 2026-2027 targeting the XFG variant ahead of the fall ...
In a randomized trial of 840 preschoolers with moderate-to-severe wheezing across 8 US pediatric ERs, azithromycin showed no ...
Halkitis, PhD, MS, MPH, dean of Rutgers School of Public Health, has had HIV for nearly 40 years and he brings up a significant point around the time of his diagnosis to the evolution of care and to ...
The expanding Gram-negative antibiotic pipeline offers important new treatment options; however, FDA approval alone does not define a drug’s place in therapy. Clinicians must weigh the clinical ...
The FDA has approved Pfizer-BioNTech's 2026-2027 Comirnaty XFG formula, an updated COVID-19 vaccine targeting the XFG variant, for adults 65 and older and for individuals ages five through 64 with at ...
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
A shortened, response-tailored antibiotic treatment of infective endocarditis was associated with longer survival, but higher incidence of relapse. Patients with infective endocarditis who were ...
The FDA has approved formulations for the 2026-2027 vaccines including Pfizer-BioNTech's Comirnaty XFG, Novavax's commercial partners Sanofi and Takeda have secured approvals for its Nuvaxovid, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results